Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec;43(12):1491-1494.
doi: 10.1111/pace.14101. Epub 2020 Oct 30.

Fracture of an S-ICD lead after two prior transvenous lead-related complications with conventional defibrillators

Klaus-Jürgen Gutleben  1 , Valjbona Nelovic  1 , Krzysztof Pujdak  1 , Marc Werner  1 , Ibrahim Osmani  1 , Jan Kähler  1
Affiliations
Case Reports

Fracture of an S-ICD lead after two prior transvenous lead-related complications with conventional defibrillators

Klaus-Jürgen Gutleben et al. Pacing Clin Electrophysiol. 2020 Dec.

Abstract

Six months after subcutaneous implantable cardioverter defibrillator (S-ICD) implantation a 26-year-old Brugada patient presented because of a beeping tone emitted by his device. Chest X-ray displayed two functionless transvenous shock leads and the S-ICD system with a lead fracture. During lead revision procedure, extensive preparation of the lead from unexpectedly firm surrounding fibrous tissue encapsulating the lead was necessary before it could be removed, and a new shock lead could be implanted. This is the first report of an S-ICD lead exchange due to very early lead fracture and unexpectedly severe fibrous tissue hampering surgical lead extraction.

Keywords: implantable defibrillator; lead failure; subcutaneous defibrillator.

PubMed Disclaimer

References

REFERENCES

    1. Priori S, Blomström-Lundqvist C, Mazzanti A, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793-2867.
    1. Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35:1186-1194.
    1. Kleemann T, Nonnenmacher F, Strauss M, et al. Long-term performance and lead failure analysis of the durata defibrillation lead compared to its previous model, the recalled Riata defibrillation lead. J Cardiovasc Electrophysiol. 2019;30:2012-2019.
    1. Baalman SWE, Quast ABE, Brouwer TF, Knops RE. An overview of clinical outcomes in transvenous and subcutaneous ICD patients. Curr Cardiol Rep. 2018;20:72.
    1. Olde Nordkamp LR, Knops RE, Bardy GH, et al. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J. 2012;163:753-760.

Publication types